Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000926236-06-000043
Filing Date
2006-03-31
Accepted
2006-03-31 14:52:34
Documents
8
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10K YEAR ENDED DECEMBER 31, 2005 cli05q4.txt 10-K 272010
2 EMPLOYEE STOCK PURCHASE PLAN AMENDMENT NO. 2 exh10-35.txt EX-10.35 1401
3 SUBSIDIARIES exh21-1.txt EX-21.1 863
4 CONSENT exh23-1.txt EX-23.1 1477
5 RULE 13A-14(A) CERTIFICATION exh31-1.txt EX-31.1 3485
6 RULE 13A-14(A) CERTIFICATION exh31-2.txt EX-31.2 3543
7 SECTION 906 CERTIFICATION exh32-1.txt EX-32.1 1468
8 SECTION 906 CERTIFICATION exh32-2.txt EX-32.2 1452
  Complete submission text file 0000926236-06-000043.txt   287180
Mailing Address 2001 WALNUT HILL LANE IRVING TX 75038
Business Address 2001 WALNUT HILL LANE IRVING TX 75038 972-518-1300
CARRINGTON LABORATORIES INC /TX/ (Filer) CIK: 0000718007 (see all company filings)

EIN.: 751435663 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10862 | Film No.: 06728072
SIC: 2834 Pharmaceutical Preparations